Daré Bioscience (DARE) Proxy filing summary

Executive summary

• Special meeting set for November 10, 2026, at 9:00 a.m. Pacific Time, entirely online; stockholders will vote on warrant-share issuance approval and possible adjournment.

Voting matters and shareholder proposals

• Proposal 1 seeks Nasdaq-rule approval for potential issuance of up to 8,934,345 common shares upon exercise of warrants issued in the August 2026 financing.

• Proposal 2 seeks authority to adjourn if needed to solicit more votes for Proposal 1; both proposals require a majority of votes cast, with a quorum of one-third of outstanding voting power.

• The board recommends voting FOR both proposals; abstentions have no effect on either outcome.

Board of directors and corporate governance

• The meeting will be virtual; record holders can vote online, by phone, or by mail, and beneficial owners should follow their broker or bank’s voting instructions.